NCT00361582View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

669

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

OsteoarthritisPain AssessmentArthralgia

Interventions

DRUG

CG5503 IR; tapentadol

Sponsors

Collaborators (1)

Grünenthal GmbH

All Listed Sponsors

collaborator

Grünenthal GmbH

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY